Retinoblastoma campaign will alert parents to warning signs

Article

The warning signs of childhood eye cancer retinoblastoma will be included in the new edition of the Personal Child Health Record.

The warning signs of childhood eye cancer retinoblastoma will be included in the new edition of the Personal Child Health Record.

The Childhood Eye Cancer Trust (CHECT) conducted the campaign, supported by Vision Express and Mumsnet, to create approved publications for parents on the warnings signs of retinoblastoma.

Joy Felgate, chief executive of the CHECT, said, "Early diagnosis is essential to offer the child the best chance of saving their sight and their eyes- parents need this information to enable them to act immediately if they notice the symptoms in their child's eyes. We are delighted the importance of this information for parents has been recognized and our recommended changes have been approved.”

Jonathan Lawson, chief executive at Vision Express, said, "This is a fantastic achievement for CHECT staff and members, who work tirelessly to raise awareness of eye cancer in children. Vision Express continues to support this worthy cause throughout its stores nationwide."

CHECT aims to campaign for further information on eye cancer symptoms to be included on the NHS Direct and Birth to Five websites. For more information please visit www.chect.org.uk

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.